A phase II study of docetaxel (Taxotere), estramustine, and low-dose hydrocortisone in men with hormone-refractory prostate cancer: preliminary results of cancer and leukemia group B Trial 9780.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples